Last reviewed · How we verify

NCT06188039: PRESCIENCE

Superior Vena Cava Collapsibility Index for Predicting Fluid Responsiveness During High-risk Non-cardiac Surgery

Completed NA Last updated 6 January 2026
What this trial tests

NA trial testing Superior vena cava collapsibility index in Surgery in 150 participants. Completed in 18 November 2025.

Timeline
3 January 2024
Primary endpoint
17 November 2025
18 November 2025

Quick facts

Lead sponsorUniwersytecki Szpital Kliniczny w Opolu
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposediagnostic
Enrollment150
Start date3 January 2024
Primary completion17 November 2025
Estimated completion18 November 2025
Sites1 location across Poland

Drugs / interventions tested

Conditions studied

Sponsor

Uniwersytecki Szpital Kliniczny w Opolu — full company profile →

Who can join

18 and older, any sex, with Surgery or Fluid Responsiveness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this prospective study is to validate the superior vena cava collapsibility index (SVC-CI) as a predictor of fluid responsiveness during laparotomy and open aortic surgery. The SVC-CI and patients' response to fluid will be assessed based on transesophageal echocardiography. The study has three arms, in order to validate SVC-CI under the conditions of laparotomy, aortic cross clamping and high PEEP levels. One of the study arms will be an active comparator arm. The data obtained from this study may help physicians guide intraoperative fluid therapy in a more efficient manner, in order to decrease perioperative mortality.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Surgery

Currently open trials in the same condition.

Other Uniwersytecki Szpital Kliniczny w Opolu trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06188039.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing